Literature DB >> 19832838

Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas.

Craig Horbinski1, Ronald L Hamilton, Colleen Lovell, Judith Burnham, Ian F Pollack.   

Abstract

Pilocytic astrocytoma (PA) is the most common glioma in the pediatric population. PAs can exhibit variable behavior that does not always correlate with location, yet at present there is no way to predict which tumors will be more aggressive. To address this problem, an institutional cohort of 147 PAs (118 with outcome data) from both cerebellar and noncerebellar locations (spine, diencephalon, midbrain, brainstem and cortex) was utilized. Parameters included quantification of characteristic morphologic variables as well as genes previously shown to be of relevance in high-grade gliomas, including MIB-1, p53 and MGMT. In this cohort, the classic biphasic appearance was most common in cerebellar tumors, whereas noncerebellar tumors were predominantly microcystic. Associations with outcome suggest that the presence of degenerative atypia may be a favorable factor in PAs. Oligodendroglial morphology and the absence of leptomeningeal invasion are adverse histologic factors, but only in cerebellar tumors. Conversely, MIB-1 proliferation index and p53 and MGMT expression do not correlate with outcome. Morphologic biomarkers thus do exist for PAs, but the utility of each biomarker varies according to location. These results suggest that PAs differ fundamentally according to location; therefore, biological behavior may not simply depend on extent of resection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19832838     DOI: 10.1111/j.1750-3639.2009.00336.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas.

Authors:  Craig Horbinski; Ronald L Hamilton; Yuri Nikiforov; Ian F Pollack
Journal:  Acta Neuropathol       Date:  2010-01-01       Impact factor: 17.088

2.  Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.

Authors:  Linda R Margraf; Lynn Gargan; Yasmeen Butt; Nirupa Raghunathan; Daniel C Bowers
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

Review 3.  Pediatric cerebellar astrocytoma: a review.

Authors:  Christopher M Bonfield; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

4.  Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas.

Authors:  Craig Horbinski; Julia Kofler; Gabrielle Yeaney; Sandra Camelo-Piragua; Sriram Venneti; David N Louis; Arie Perry; Geoffrey Murdoch; Marina Nikiforova
Journal:  Brain Pathol       Date:  2011-03-14       Impact factor: 6.508

5.  Primary spinal pilocytic astrocytoma: clinical study with long-term follow-up in 16 patients and a literature review.

Authors:  Yong Jiang; Liang Lv; Senlin Yin; Peizhi Zhou; Shu Jiang
Journal:  Neurosurg Rev       Date:  2019-05-16       Impact factor: 3.042

Review 6.  The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

Authors:  Craig Horbinski; Keith L Ligon; Priscilla Brastianos; Jason T Huse; Monica Venere; Susan Chang; Jan Buckner; Timothy Cloughesy; Robert B Jenkins; Caterina Giannini; Roger Stupp; L Burt Nabors; Patrick Y Wen; Kenneth J Aldape; Rimas V Lukas; Evanthia Galanis; Charles G Eberhart; Daniel J Brat; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

7.  Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.

Authors:  Craig Horbinski; Marina N Nikiforova; Jill M Hagenkord; Ronald L Hamilton; Ian F Pollack
Journal:  Neuro Oncol       Date:  2012-04-05       Impact factor: 12.300

8.  Insulin-like growth factor 2 mRNA binding protein 3 expression is an independent prognostic factor in pediatric pilocytic and pilomyxoid astrocytoma.

Authors:  Valerie N Barton; Andrew M Donson; Diane K Birks; Bette K Kleinschmidt-DeMasters; Michael H Handler; Nicholas K Foreman; Sarah Z Rush
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

9.  BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors.

Authors:  Efthymios Dimitriadis; George A Alexiou; Panagiota Tsotsou; Efthymia Simeonidi; Kalliopi Stefanaki; Amalia Patereli; Neofytos Prodromou; Nikolaos Pandis
Journal:  J Neurooncol       Date:  2013-04-24       Impact factor: 4.130

10.  Transcriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features.

Authors:  Krzysztof Zakrzewski; Michał Jarząb; Aleksandra Pfeifer; Małgorzata Oczko-Wojciechowska; Barbara Jarząb; Paweł P Liberski; Magdalena Zakrzewska
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.